Why the study?
Are plasma levels of tissue factor pathway inhibitor (TFPI) increased in patients with acute myocardial infarction compared to other thrombotic conditions and healthy volunteers?
Are plasma levels of tissue factor pathway inhibitor (TFPI) increased in patients with acute myocardial infarction compared to other thrombotic conditions and healthy volunteers?
Answers are grounded in this paper and cite their sources.
TFPI levels are significantly elevated in AMI compared to other thrombotic conditions and transiently increase further following PTCA, suggesting release from ischemic tissues.
We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antithrombin complex (TAT), and plasmin-plasmin inhibitor complex (PPIC) were significantly increased. Both the plasma total TFPI and free-TFPI levels in the AMI patients were significantly higher than those in the healthy volunteers, PE patients, and DVT patients. There was no significant difference in total TFPI or free-TFPI among patients with PE, those with DVT, and healthy volunteers. One hour after percutaneous transluminal coronary angioplasty (PTCA) in the AMI group, the total TFPI level was further increased, and it was significantly reduced 24 hr after PTCA, to a level similar to that in healthy volunteers. Free-TFPI showed a pattern similar to that of total TFPI. The ratio of free-TFPI/total TFPI was highest 1 hr after PTCA. Increased TFPI in AMI patients might be released from ischemic tissues.
No takes yet. Share an insight, caveat, or question.
Kamikura et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: